Skip to main content
Contact +1 (919) 234-1277

🚀 Special Offer🚀Get 25% off on your bioreagent online order (except Micelles and Nanodiscs), with the code: PROTEOSHOP25

📢 New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now
Nycodenz AG® Nycodenz AG® XtenCHO ™ Race Starter kit XtenCHO ™ Race Starter kit
View all Products

Vanucizumab Biosimilar – Anti-ANGPT2, VEGFA, mAb – Research Grade

Reference:
Product Image
Vanucizumab Biosimilar - Anti-ANGPT2, VEGFA, mAb binds to Human ANGPT2 in indirect ELISA Assay
Product Image
Vanucizumab Biosimilar - Anti-ANGPT2, VEGFA, mAb binds to Human ANGPT2 in indirect ELISA Assay
Size

100ug, 1MG
Isotype

VH-C-kappa-CH2-CH3_V-lambda-CH1_H-GAMMA-1_L-kappa
Brand

ProteoGenix
Product type

Primary Antibodies
Clonality

Monoclonal Antibody
Expression system

Mammalian cells
Applications

Elisa, WB
Tags:
Specification
Description
Documents
QC & Validation Data1
Reviews
Product nameVanucizumab Biosimilar - Anti-ANGPT2, VEGFA, mAb - Research Grade
SourceCAS 1448221-05-3
SpeciesHumanized
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsVanucizumab,RG-7221,RG7221,RO5520985,ANGPT2, VEGFA, ,anti-ANGPT2, VEGFA,
ReferencePX-TA1355
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeVH-C-kappa-CH2-CH3_V-lambda-CH1_H-GAMMA-1_L-kappa
ClonalityMonoclonal Antibody

Description of Vanucizumab Biosimilar - Anti-ANGPT2, VEGFA, mAb - Research Grade

General information on Anti-ANGPT2/VEGFA[Homo sapiens], (Vanucizumab) Monoclonal Antibody

Vanucizumab has been investigated for the treatment of Colorectal Cancer and Advanced/Metastatic Solid Tumors.

Datasheet Download
MSDS Download

Vanucizumab Biosimilar - Anti-ANGPT2, VEGFA, mAb binds to Human ANGPT2 in indirect ELISA Assay

Immobilized Human ANGPT2-Ang2 recombinant protein (cat. No. PX-P6245) at 0.5µg/mL (100µL/well) can bind Vanucizumab Biosimilar - Anti-ANGPT2, VEGFA, mAb (cat. No. PX-TA1355) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450 giving an EC50 at 105.6M.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Vanucizumab Biosimilar – Anti-ANGPT2, VEGFA, mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human VEGF Recombinant Protein
Antigen

Human VEGF Recombinant Protein

PX-P1060 250$
View product
Human V-set domain-containing T-cell activation inhibitor 1(VTCN1)/B7H4 recombinant protein
Antigen

Human V-set domain-containing T-cell activation inhibitor 1(VTCN1)/B7H4 recombinant protein

PX-P4045 250$
View product
ICOS Protein – Human CD278 Recombinant Protein
Antigen

ICOS Protein – Human CD278 Recombinant Protein

PX-P4035 250$
View product
IGFBP1 protein – Human IGFBP1 full length Recombinant Protein
Antigen

IGFBP1 protein – Human IGFBP1 full length Recombinant Protein

PX-P2077 250$
View product
IL6 Protein – Interleukin-6(IL6)
Antigen

IL6 Protein – Interleukin-6(IL6)

PX-P4592 146$
View product
Immunoglobulin G-binding protein G(spg) His Tag
Antigen

Immunoglobulin G-binding protein G(spg) His Tag

PX-P4645 169$
View product
Indoleamine 2,3-dioxygenase 2(IDO2)
Antigen

Indoleamine 2,3-dioxygenase 2(IDO2)

PX-P4851 217$
View product
Vanucizumab ELISA Kit
ELISA

Vanucizumab ELISA Kit

KPTX118 1403$
View product

Contact us

Send us a message from the form below

    Cart (0 Items)

    Your cart is currently empty.

    View Products